BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34551831)

  • 1. Slowing on quantitative EEG is associated with transition to dementia in mild cognitive impairment.
    Hamilton CA; Schumacher J; Matthews F; Taylor JP; Allan L; Barnett N; Cromarty RA; Donaghy PC; Durcan R; Firbank M; Lawley S; O'Brien JT; Roberts G; Thomas AJ
    Int Psychogeriatr; 2021 Dec; 33(12):1321-1325. PubMed ID: 34551831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Alzheimers Res Ther; 2020 Jul; 12(1):82. PubMed ID: 32641111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of quantitative EEG in early Lewy body disease.
    Massa F; Meli R; Grazzini M; Famà F; De Carli F; Filippi L; Arnaldi D; Pardini M; Morbelli S; Nobili F
    Parkinsonism Relat Disord; 2020 Jun; 75():70-75. PubMed ID: 32480310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies.
    Bonanni L; Perfetti B; Bifolchetti S; Taylor JP; Franciotti R; Parnetti L; Thomas A; Onofrj M
    Neurobiol Aging; 2015 Jan; 36(1):434-45. PubMed ID: 25129239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of autonomic symptoms may assist with early identification of mild cognitive impairment with Lewy bodies.
    Hamilton CA; Frith J; Donaghy PC; Barker SAH; Durcan R; Lawley S; Barnett N; Firbank M; Roberts G; Taylor JP; Allan LM; O'Brien J; Yarnall AJ; Thomas AJ
    Int J Geriatr Psychiatry; 2022 Apr; 37(4):. PubMed ID: 35302677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodromal Dementia With Lewy Bodies: Clinical Characterization and Predictors of Progression.
    van de Beek M; van Steenoven I; van der Zande JJ; Barkhof F; Teunissen CE; van der Flier WM; Lemstra AW
    Mov Disord; 2020 May; 35(5):859-867. PubMed ID: 32048343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of the pareidolia test in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Hamilton CA; Matthews FE; Allan LM; Barker S; Ciafone J; Donaghy PC; Durcan R; Firbank MJ; Lawley S; O'Brien JT; Roberts G; Taylor JP; Thomas AJ
    Int J Geriatr Psychiatry; 2021 Sep; 36(9):1407-1414. PubMed ID: 33772864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical symptoms in mild cognitive impairment with Lewy bodies: Frequency, time of onset, and discriminant ability.
    Donaghy PC; Hamilton C; Durcan R; Lawley S; Barker S; Ciafone J; Barnett N; Olsen K; Firbank M; Roberts G; Lloyd J; Allan LM; Saha R; McKeith IG; O'Brien JT; Taylor JP; Thomas AJ
    Eur J Neurol; 2023 Jun; 30(6):1585-1593. PubMed ID: 36912421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Neuroimage Clin; 2021; 30():102604. PubMed ID: 33711623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis.
    Hamilton CA; Donaghy PC; Durcan R; Ciafone J; Olsen K; Roberts G; Firbank MJ; Allan LM; Taylor JP; O'Brien JT; Thomas AJ
    Neurology; 2024 Jul; 103(2):e209499. PubMed ID: 38870460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease.
    Thomas AJ; Hamilton CA; Heslegrave A; Barker S; Durcan R; Lawley S; Barnett N; Lett D; Firbank M; Roberts G; Taylor JP; Donaghy PC; Zetterberg H; O'Brien J
    Mov Disord; 2022 Jul; 37(7):1495-1504. PubMed ID: 35318733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms associated with Lewy body disease in mild cognitive impairment.
    Donaghy PC; Barnett N; Olsen K; Taylor JP; McKeith IG; O'Brien JT; Thomas AJ
    Int J Geriatr Psychiatry; 2017 Nov; 32(11):1163-1171. PubMed ID: 28556415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective predictors of decline
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; McKeith IG; Thomas AJ
    Psychol Med; 2021 Nov; 51(15):2590-2598. PubMed ID: 32366348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory impairment in mild cognitive impairment with Lewy bodies and Alzheimer's disease.
    Thomas AJ; Hamilton CA; Barker S; Durcan R; Lawley S; Barnett N; Firbank M; Roberts G; Allan LM; O'Brien J; Taylor JP; Donaghy PC
    Int Psychogeriatr; 2022 Jun; 34(6):585-592. PubMed ID: 34666863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    Babiloni C; Del Percio C; Lizio R; Noce G; Lopez S; Soricelli A; Ferri R; Pascarelli MT; Catania V; Nobili F; Arnaldi D; Famà F; Aarsland D; Orzi F; Buttinelli C; Giubilei F; Onofrj M; Stocchi F; Vacca L; Stirpe P; Fuhr P; Gschwandtner U; Ransmayr G; Garn H; Fraioli L; Pievani M; Frisoni GB; D'Antonio F; De Lena C; Güntekin B; Hanoğlu L; Başar E; Yener G; Emek-Savaş DD; Triggiani AI; Franciotti R; Taylor JP; De Pandis MF; Bonanni L
    J Alzheimers Dis; 2018; 62(1):247-268. PubMed ID: 29439335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    Liu S; Liu C; Hu W; Ji Y
    J Alzheimers Dis; 2022; 89(3):923-929. PubMed ID: 35988221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    Smailovic U; Kåreholt I; Koenig T; Ashton NJ; Winblad B; Höglund K; Nilsson P; Zetterberg H; Blennow K; Jelic V
    J Alzheimers Dis; 2021; 83(1):355-366. PubMed ID: 34334389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric profiles in mild cognitive impairment with Lewy bodies.
    Liu C; Liu S; Wang X; Ji Y
    Aging Ment Health; 2021 Nov; 25(11):2011-2017. PubMed ID: 32896168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.
    Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Colloby SJ; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Psychol Med; 2018 Oct; 48(14):2384-2390. PubMed ID: 29362011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.